Form 4: Accolade Inc. Executive Richard Eskew Reports Acquisition of Common Stock
SEC Form 4
Richard Eskew, EVP General Counsel of Accolade, Inc., reports acquiring 805 shares of common stock through the company's Employee Stock Purchase Plan at a price of $6.53 per share.
Summary
- Richard Eskew, the EVP General Counsel of Accolade, Inc., filed a Form 4 on May 24, 2024, reporting a transaction.
- On May 22, 2024, Eskew acquired 805 shares of Accolade's common stock.
- The shares were purchased through the company's 2020 Employee Stock Purchase Plan (ESPP) at a price of $6.53 per share.
- This price represents 85% of the closing price of Accolade's common stock on May 20, 2024.
- Following the transaction, Eskew directly owns 40,982 shares of Accolade's common stock.
- The transaction is exempt under Rule 16b-3(c).
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a routine transaction under the ESPP. It indicates insider confidence but doesn't provide significant new information.
Positives
- The acquisition of shares through the ESPP demonstrates the executive's investment in the company's future.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor management's alignment with shareholder interests.
Stakeholder Impact
- The transaction provides stakeholders with insight into management's investment in the company.
Key Dates
| Date | Description |
|---|---|
| 05/20/2024 | ESPP purchase period ending date; used to determine the purchase price. |
| 05/22/2024 | Date of the transaction (acquisition of shares). |
| 05/24/2024 | Date the Form 4 was signed. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.